Under construction – not a live service
Sign in
Not yet recruitingNo phase

Exploration of Current and New Technologies for Accuracy of Diagnosing OSA

Key facts

Who runs it
ResMed
Where
Australia5 sites in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
90 people, planned
Started
Sept 2026
Planned end
Oct 2026
Type of study
Observational
Treatments tested
  • Device A
  • Device B
  • Device C
  • Device D
  • Device E
  • Screener A
Record updated
19 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Participant is 18 years of age or older
  • Participant is willing to provide informed consent
  • Participant is willing to participate in all study related procedures

Who cannot take part

  • Unable to cease PAP therapy during PSG (if currently using)
  • Requires use of oxygen therapy during sleep
  • Diagnosis of untreated clinically relevant sleep disorder (other than SDB, e.g. severe insomnia)
  • Participant has a permanent pacemaker, sustained non-sinus cardiac arrhythmias, and/or takes alpha blocker or short acting nitrate medication
  • Who are or may be pregnant
  • Participants are unsuitable to participate in the study in the opinion of the investigator
  • Shift workers who worked an overnight shift in the past 3 days
  • Participant who are contraindicated to use the NightOwl sensor

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Resmed is the manufacturer of medical devices which screen, diagnose, treat and monitor people with sleeping and respiratory disorders, such as obstructive sleep apnea (OSA).

Read full original descriptionShow less

From time to time, for regulatory, quality, and marketing purposes, there may be a need to test the various products performance against PSG (gold standard technology), and other products.

The purpose of this study is:

1. Products performance against PSG 2. comparison against other products, and 3. Assessments of potential new technologies

The group in the trial

  • OSA

    Suspected of obstructive sleep apnea and about to undergo assessment

    Treatment: Device A, Device B, Device C, Device D, Device E, and Screener A

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
19 August 2026